Loading...
research article
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
The activation of cannabinoid receptor type 2 (CB2)-mediated pathways might represent a promising anti-atherosclerotic treatment. Here, we investigated the expression of the endocannabinoid system in human carotid plaques and the impact of CB2 pharmacological activation on markers of plaque vulnerability in vivo and in vitro.
Loading...
Name
ehr449.pdf
Type
Publisher's version
Access type
openaccess
Size
495.94 KB
Format
Adobe PDF
Checksum (MD5)
9848b18c7152546fcaab9330b18f25e5